Published in Eur Respir J on August 01, 2001
Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med (2006) 2.08
A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids. Br J Pharmacol (2007) 1.71
Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev (2010) 1.52
Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. Eur J Clin Pharmacol (2009) 1.40
Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Cochrane Database Syst Rev (2010) 1.16
Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children. Cochrane Database Syst Rev (2009) 1.14
Retracted Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all? Naunyn Schmiedebergs Arch Pharmacol (2008) 1.12
A smarter way to manage asthma with a combination of a long-acting beta(2)-agonist and inhaled corticosteroid. Ther Clin Risk Manag (2007) 0.99
A comparison of budesonide/formoterol maintenance and reliever therapy vs. conventional best practice in asthma management. Int J Clin Pract (2009) 0.96
Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation. BMC Pulm Med (2011) 0.87
Inhaled steroid/long-acting beta 2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients. Respir Res (2006) 0.86
Long-acting beta(2)-agonist and inhaled corticosteroid combination therapy for adult persistent asthma: systematic review of clinical outcomes and economic evaluation. CADTH Technol Overv (2010) 0.86
Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma. Int J Clin Pract (2007) 0.84
Real-life effectiveness of budesonide/formoterol maintenance and reliever therapy in asthma patients across Asia: SMARTASIA study. BMC Pulm Med (2013) 0.81
A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany. Int J Clin Pract (2008) 0.80
Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study. Respir Res (2006) 0.79
Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study. Respir Res (2010) 0.78
Comparison and optimal use of fixed combinations in the management of COPD. Int J Chron Obstruct Pulmon Dis (2007) 0.76
Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial. BMJ Open (2015) 0.76
Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med (1999) 3.03
[German guideline for diagnosis and management of idiopathic pulmonary fibrosis]. Pneumologie (2013) 3.03
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J (2001) 2.77
Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial. Lancet (2001) 2.68
[Reliability of the presurgical anatomopathologic diagnosis in primary bronchogenic carcinoma]. Med Clin (Barc) (1997) 2.66
Guidance for contained field trials of vector mosquitoes engineered to contain a gene drive system: recommendations of a scientific working group. Vector Borne Zoonotic Dis (2008) 2.49
Reversibility of venous sinus obstruction in idiopathic intracranial hypertension. AJNR Am J Neuroradiol (2007) 1.99
Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. Respir Med (2003) 1.97
Quality assessment of genetic markers used for therapy stratification. J Clin Oncol (2003) 1.92
Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol (1985) (1993) 1.88
A critical evaluation of HIPE data. Ir Med J (2012) 1.77
Nasal CPAP therapy: effects of different CPAP levels on pressure transmission into the trachea and pulmonary oxygen transfer. Acta Anaesthesiol Scand (2002) 1.76
Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract (2007) 1.64
Clinical effectiveness of transversus abdominis plane (TAP) block in abdominal surgery: a systematic review and meta-analysis. Colorectal Dis (2012) 1.53
The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy (2005) 1.51
Cell type accuracy of bronchial biopsy specimens in primary lung cancer. Chest (1996) 1.50
Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E. Am Rev Respir Dis (1991) 1.49
Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Eur J Pediatr (2000) 1.48
Increased lung neutrophil apoptosis and inflammation resolution in nonresponding pneumonia. Eur Respir J (2011) 1.46
The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. Eur Respir J (1994) 1.42
Genetic counselling for schizophrenia in the era of molecular genetics. Can J Psychiatry (2001) 1.41
Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax (1999) 1.41
Massive pulmonary emboli associated with olanzapine. Ir Med J (2008) 1.41
[Combination of asthma and COPD: more frequent as considered to be?]. Pneumologie (2006) 1.40
Assessing the dietetic needs of different patient groups receiving enteral tube feeding in primary care. J Hum Nutr Diet (2002) 1.40
[Guideline-adherent treatment for asthma]. Internist (Berl) (2008) 1.40
[beta(2)-Sympathomimetics: risks for asthma therapy? Lessons from the SMART1 Study. A statement from the German Respiratory Tract League]. Dtsch Med Wochenschr (2007) 1.39
[The clinical characteristics of pleural tuberculosis in patients with and without human immunodeficiency virus infection]. Arch Bronconeumol (1995) 1.39
Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet. Climacteric (2005) 1.33
Primary endovascular repair of juxtarenal aneurysms with fenestrated endovascular grafting. Eur J Vasc Endovasc Surg (2004) 1.33
Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine. J Biol Chem (1990) 1.28
Safety and tolerability of omalizumab. Clin Exp Allergy (2009) 1.26
Genetic insights into the neurodevelopmental hypothesis of schizophrenia. Schizophr Bull (2001) 1.23
[Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin]. Pneumologie (2007) 1.23
Development and application of surface plasmon resonance-based biosensors for the detection of cell-ligand interactions. Anal Biochem (2000) 1.23
The older persons' assessment and liaison team 'OPAL': evaluation of comprehensive geriatric assessment in acute medical inpatients. Age Ageing (2007) 1.21
Recurrent vulvovaginal candidiasis. A gynaecological enigma. Aust Fam Physician (1989) 1.19
Effect of internal thoracic artery preparation on blood loss, lung function, and pain. Ann Thorac Surg (1999) 1.18
Elevation of total serum immunoglobulin E is associated with asthma in nonallergic individuals. Eur Respir J (2000) 1.17
Mast cell-derived tumour necrosis factor is essential for allergic airway disease. Eur Respir J (2007) 1.16
Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis. Eur Respir J (2007) 1.13
Systematic review and meta-analysis of continuous local anaesthetic wound infiltration versus epidural analgesia for postoperative pain following abdominal surgery. Br J Surg (2013) 1.13
Malignant peripheral nerve sheath tumours--report of 8 cases and review of the literature. Acta Neurochir (Wien) (2001) 1.13
Spontaneous intracranial haematomas caused by neoplasms. Acta Neurochir (Wien) (2000) 1.12
Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease. Respiration (2003) 1.10
Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany. Respir Med (2009) 1.09
Sports medicine and the accident and emergency medicine specialist. Emerg Med J (2002) 1.07
Disseminated intravascular coagulation: antithrombin, plasminogen, and coagulation abnormalities in 41 dogs. J Am Vet Med Assoc (1981) 1.07
Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet (1991) 1.07
Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung. J Clin Invest (1991) 1.06
Breastfeeding after radionuclide administration. J Hum Lact (1995) 1.06
Clinical governance: its origins and its foundations. Clin Perform Qual Health Care (2000) 1.05
[Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities]. Pneumologie (2006) 1.05
Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer. Br J Cancer (2012) 1.04
Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study. J Clin Oncol (2001) 1.04
Low-grade fibromyxoid sarcoma. Histopathology (1990) 1.04
Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group. Eur Respir J (1998) 1.03
Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid. J Appl Physiol (1985) (1993) 1.02
[The impact of COPD on hospital resources: the specific burden of COPD patients with high rates of hospitalization]. Arch Bronconeumol (2001) 1.01
Aerosolization of recombinant SLPI to augment antineutrophil elastase protection of pulmonary epithelium. J Appl Physiol (1985) (1990) 1.00
S-nitrosocysteine inhibition of human platelet secretion is correlated with increases in platelet cGMP levels. Circ Res (1991) 1.00
The 29-kDa proteins phosphorylated in thrombin-activated human platelets are forms of the estrogen receptor-related 27-kDa heat shock protein. Proc Natl Acad Sci U S A (1991) 0.99
Acute asthma during pregnancy. Thorax (1996) 0.98
Stroke pattern interpretation: the variability of hypertensive versus amyloid angiopathy hemorrhage. Cerebrovasc Dis (2001) 0.98
Duration of length of stay in pneumonia: influence of clinical factors and hospital type. Eur Respir J (2003) 0.97
Cough reflex testing with inhaled capsaicin in the study of chronic cough. Respir Med (2003) 0.97
Initial risk class and length of hospital stay in community-acquired pneumonia. Eur Respir J (2001) 0.97
Alpha1-antitrypsin deficiency: biological answers to clinical questions. Am J Med Sci (2001) 0.97
Glutathione in induced sputum of healthy individuals and patients with asthma. Thorax (2001) 0.97
Measuring asthma control: a comparison of three classification systems. Eur Respir J (2010) 0.96
Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals. Am J Respir Crit Care Med (1995) 0.96
Goserelin with chemotherapy to preserve ovarian function in pre-menopausal women with early breast cancer: menstruation and pregnancy outcomes. Ann Oncol (2012) 0.96
Oral supplementation with whey proteins increases plasma glutathione levels of HIV-infected patients. Eur J Clin Invest (2001) 0.96
Nodding syndrome since 2012: recent progress, challenges and recommendations for future research. Trop Med Int Health (2014) 0.96
Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis. Eur Respir J (2002) 0.95
Single-step separation of platelets from whole blood coupled with digital quantification by interfacial platelet cytometry (iPC). Langmuir (2010) 0.95
Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors. J Clin Oncol (2001) 0.94
A clinical comparison of hydrocortisone butyrate with oxytetracycline/hydrocortisone acetate-polymyxin B in the local treatment of acute external otitis. Eur Arch Otorhinolaryngol (1990) 0.93
Surgical treatment of septic deep venous thrombosis. Surgery (1995) 0.93
Symptoms in patients with peptic ulcer and hematemesis and/or melena related to the use of non-steroid anti-inflammatory drugs. Scand J Gastroenterol (1985) 0.93
Sputum levels of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, and their ratio correlate with airway obstruction in lung transplant recipients: relation to tumor necrosis factor-alpha and interleukin-10. J Heart Lung Transplant (2001) 0.93
Glutathione aerosol suppresses lung epithelial surface inflammatory cell-derived oxidants in cystic fibrosis. J Appl Physiol (1985) (1999) 0.93
Study of clinical features of amyloid angiopathy hemorrhage and hypertensive intracerebral hemorrhage. J Zhejiang Univ Sci (2004) 0.93
Postural relief of dyspnoea in severe chronic airflow limitation: relationship to respiratory muscle strength. Thorax (1983) 0.92
Recommendations for management of equine athletes with cardiovascular abnormalities. J Vet Intern Med (2014) 0.92
Asthma care and factors affecting medication compliance: the patient's point of view. Int J Qual Health Care (2001) 0.92
17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group. Med Pediatr Oncol (2001) 0.92
Single-primer amplification of flanking sequences. Biotechniques (2000) 0.91
Asthma nurse practice--a resource-effective approach in asthma management. Respir Med (1999) 0.91
A cost-effectiveness study comparing the as-needed use of formoterol (Oxis) and terbutaline (Bricanyl) in patients with moderate to severe asthma. Respir Med (2001) 0.91
Pneumothorax in the Ehlers-Danlos syndrome. Ir J Med Sci (1981) 0.91
Factors affecting sexuality in older Australian women: sexual interest, sexual arousal, relationships and sexual distress in older Australian women. Climacteric (2006) 0.91
The prevalence of asymptomatic gastroesophageal reflux in bronchial asthma and in non-asthmatic individuals. Eur J Respir Dis (1983) 0.90
The effects of chronic hyperinflation, nutritional status, and posture on respiratory muscle strength in cystic fibrosis. Am Rev Respir Dis (1983) 0.90
Daughters and mothers exercising together (DAMET): a 12-week pilot project designed to improve physical self-perception and increase recreational physical activity. Women Health (2001) 0.90
Defining the sports medicine specialist in the United Kingdom: a Delphi study. Br J Sports Med (2004) 0.90
Budesonide/formoterol adjustable maintenance dosing reduces asthma exacerbations versus fixed dosing. Int J Clin Pract (2003) 0.90
Effects of long-term supplementation with whey proteins on plasma glutathione levels of HIV-infected patients. Eur J Nutr (2002) 0.90
[Guidelines for the diagnosis and treatment chronic obstructive bronchitis and pulmonary emphysema issued by Deutsche Atemwegsliga and Deutsche Gesellschaft für pneumologie]. Pneumologie (2002) 0.90